Press release
Dengue Testing Market is forecasted to reach a valuation of US$ 739.4 Mn with CAGR of 6.4% during 2022-2025
Dengue Testing Market 2022
Government tendering and partnerships between diagnostic kit manufacturers are expected to provide long-term opportunities to the manufacturers in the dengue testing market. Governments in countries of Latin America and Asia Pacific are laying emphasis to eradicate diseases that have a higher infection rate by providing free diagnosis tests and medication to the underprivileged with the help of various government-funded programs. However, in order to achieve these objectives, the local authorities need a constant supply of related diagnostic kits.
Governments rely on tendering or partnerships with manufacturers for delivering the required kits. Such kind of mechanisms also provide a stable financial flow to the manufacturers for a particular period.
Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/22738
These are some of the important findings of the latest report released by Persistence Market Research which is titled as 'Dengue Testing Market: Global Industry Analysis 2012-2016 and Forecast 2017 - 2025'. Besides the qualitative analysis on the market dynamics operating in the global dengue testing market, the report also features a comprehensive quantitative assessment of the various segments and regions that are prominent in this market. As per the numbers that are given in this report, the global dengue testing market was valued at US$ 451.6 Mn in 2017 and is forecasted to reach a valuation of US$ 739.4 Mn in 2025, displaying a CAGR of 6.4% during the period of assessment 2017-2025.
Company Profiles:
Abnova Corporation
Roche Molecular Systems Inc.
Abbott Laboratories
InBios International, Inc.
NovaTec Immundiagnostica GmbH
Euroimmun AG (Sub. PerkinElmer)
Quest Diagnostics
Certest Biotec S.L.
OriGene Technologies
Thermo Fisher Scientific Inc.
Others.
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/22738
Global Dengue Testing Market: Dynamics
To control the spread of dengue fever, reduce the number of deaths and prevent its reoccurrence in the future, governments across the world have adopted various comprehensive dengue control policies that basically focus on prevention and cure. The multi-pronged efforts for dengue control include provision of diagnosis and treatment facilities for dengue fever at all the health centers and adoption of preventive measures. Various countries have set up their own national programs such as the National Dengue Prevention and Control Program in countries such as Indonesia, Brazil, India and Philippines. The World Mosquito Program, formerly known as Eliminate Dengue is helping to protect the global population from mosquito-borne diseases. Such type of interventions are boosting the global dengue testing market all over the world.
However, despite the high level of awareness for dengue prevention and cure, there are various challenges such as inadequate funding and resources and a lack of sound strategy to respond to the increasing problems related to dengue outbreaks in various regions of the world. Rapid urbanization, lack of sanitation, increase in international trade and mobility of population restraint the efforts to control dengue. In addition, lack of well-organized dengue control programs in collaboration with different sectors and agencies also restraints the market growth of dengue testing.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/22738
Global Dengue Testing Market: Segmentation and Forecast
The global dengue testing market is segmented on the basis of product type, end-user and region.
ELISA based tests segment accounted for 46.6% share in 2016 and is projected to account for 46.5% share by 2025 end in the global dengue testing market.
The hospitals segment was valued at US$ 196.9 Mn in 2017 and is projected to reach a valuation of US$ 334.4 Mn in 2025, registering a CAGR of 6.8% during the period of assessment.
Middle East and Africa dengue testing market was valued at US$ 139.7 Mn in 2017.
Read Also-
Dengue Rapid Tests Market - https://www.persistencemarketresearch.com/market-research/dengue-rapid-tests-market.asp
Contact us:
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
About us:
PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against rep/uted organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Dengue Testing Market is forecasted to reach a valuation of US$ 739.4 Mn with CAGR of 6.4% during 2022-2025 here
News-ID: 2596854 • Views: …
More Releases from Persistence Market Research
Antimicrobial Additives Market Expected to Grow at 7.8% CAGR Between 2025 and 20 …
The antimicrobial additives market has evolved into a critical segment within the global specialty chemicals and materials landscape, driven by the growing need to control microbial contamination across healthcare, food packaging, construction, automotive, and consumer goods industries. Antimicrobial additives are incorporated into materials such as plastics, coatings, textiles, and papers to inhibit the growth of bacteria, fungi, and other microorganisms throughout a product's lifecycle. Their role has expanded beyond basic…
Smart Manufacturing Market Valued at US$394.4 Billion in 2025, Expected to Reach …
The smart manufacturing market represents a fundamental transformation in how goods are designed, produced, monitored, and delivered across global industries. It combines advanced digital technologies such as industrial Internet of Things (IIoT), artificial intelligence (AI), machine learning, robotics, cloud computing, digital twins, and advanced analytics to create highly connected, automated, and intelligent production environments. Unlike traditional manufacturing, smart manufacturing enables real-time decision-making, predictive maintenance, adaptive production planning, and end-to-end visibility…
Oligonucleotide Synthesis Market Forecast Signals Strong Expansion During 2025-2 …
The oligonucleotide synthesis market has evolved from a niche research-support function into a strategic pillar of modern biotechnology and pharmaceutical development. Oligonucleotides-short, synthetically produced DNA or RNA sequences-are indispensable in applications ranging from basic genetic research and molecular diagnostics to advanced therapeutics such as antisense oligonucleotides (ASOs), small interfering RNAs (siRNAs), and RNA- and DNA-based vaccines. As precision medicine continues to reshape healthcare, the ability to reliably synthesize high-quality, customized…
Genome Editing Market Demand Surges Across Biotechnology and Pharmaceutical Sect …
The genome editing market has emerged as one of the most transformative segments within modern biotechnology, reshaping how scientists, clinicians, and agricultural innovators approach genetic modification. Genome editing refers to a suite of technologies that allow precise alterations to DNA within living organisms, enabling the correction of genetic defects, enhancement of desirable traits, and development of advanced therapeutic solutions. Over the past decade, breakthroughs such as CRISPR/Cas9, base editing, and…
More Releases for Dengue
Key Trend Reshaping the Dengue Treatment Market in 2025: Innovative Drug Deliver …
Which drivers are expected to have the greatest impact on the over the dengue treatment market's growth?
The escalation in cases of dengue is projected to stimulate the expansion of the market for dengue treatments. Dengue is a viral infection transmitted by mosquito bites, causing symptoms akin to the flu and can escalate to intense complications if not treated. The escalation is primarily due to progressing urbanization, climate alterations favourable to…
Key Dengue Vaccine Market Trend for 2025-2034: Advancements In Dengue Tetravalen …
What Is the Future Outlook for the Dengue Vaccine Market's Size and Growth Rate?
In the past few years, the dengue vaccine market has experienced significant growth. From $0.64 billion in 2024, it is projected to reach $0.72 billion in 2025, marking a compound annual growth rate (CAGR) of 12.4%. This notable expansion during the historical period can be credited to factors such as an increase in travel and urbanization trends,…
Dengue Vaccine Market : An Detailed Overview
Introduction:
Dengue fever is a mosquito-borne viral infection caused by the dengue virus, transmitted primarily through Aedes aegypti and Aedes albopictus mosquitoes. Affecting millions globally each year, dengue has become a significant public health concern, especially in tropical and subtropical regions. The development of dengue vaccines represents a groundbreaking advancement in preventing the disease, reducing its associated healthcare costs, and controlling outbreaks. With increasing awareness and investments in immunization programs, the…
Dengue Vaccine Market : An Overview
Introduction:
Dengue fever is a mosquito-borne viral infection that has become a significant public health challenge in tropical and subtropical regions. The disease is caused by the dengue virus, which is transmitted primarily by Aedes aegypti mosquitoes. With approximately 390 million infections annually, dengue fever places a substantial burden on healthcare systems and economies worldwide. Efforts to mitigate this burden have led to the development of dengue vaccines, designed to prevent…
"Rising Incidence of Dengue Fever Propels Dengue Virus Diagnostic Tests Market T …
According to WHO, dengue affects about 50-100 million people worldwide, annually. It is a vector-borne highly communicable disease. This report discusses the diagnostic tests used to confirm the presence of dengue in one individual.
It is true that the growth of the global dengue virus diagnostic tests market is primarily driven by an increase in the incidence of dengue fever, which is a mosquito-borne viral infection that can cause severe flu-like…
Dengue Vaccines Market 2021 | Detailed Report
Dengue Vaccines Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027.
Get Free Sample PDF (including full TOC, Tables and Figures) of Dengue Vaccines Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4644240
The report provides a comprehensive analysis of company profiles listed below:
- Sanofi
- Takeda
Dengue Vaccines Market Segment by…
